The industry is right to welcome funding for the National One Stop Shop for clinical trials but it should be very cautious in supporting language that confuses this with actual funded access to proven treatments.
Access should not be redefined as including access via a clinical trial
May 3, 2024 Latest NewsBioPharmaComment
Latest Video
New Stories
-
The 'Dispatched' Week in Review Podcast - 13 November
November 13, 2026 - - Podcast -
There is no need for AI to automate the care out of healthcare, Cohn warns
November 13, 2026 - -
A year on, Sanofi now asks staff to explain how they used AI
November 13, 2026 - - Latest News -
Longevity Life Sciences welcomes longer TGA exclusivity and calls for existing ingredients to be included
November 13, 2026 - - Latest News -
Cochlear's global government affairs chief is putting AI to work
November 13, 2026 - - Latest News -
Institutions cannot outrun the disruptive impact of technological change forever
November 12, 2026 - - Latest News -
Patients tired of polite nods turning to AI to force Canberra's hand
November 12, 2026 - - Latest News

